Journal Article

Schizophrenia, Alzheimer's Disease, and Anti-inflammatory Agents

Robert J. Oken and Patrick L. McGeer

in Schizophrenia Bulletin

Published on behalf of Maryland Psychiatric Research Center

Volume 22, issue 1, pages 1-4
Published in print January 1996 | ISSN: 0586-7614
e-ISSN: 1745-1701 | DOI:
Schizophrenia, Alzheimer's Disease, and Anti-inflammatory Agents

More Like This

Show all results sharing this subject:

  • Child and Adolescent Psychiatry


Show Summary Details


Some recent postmortem reports raise the possibility that Alzheimer-type pathology may be 6 to 12 times higher in elderly schizophrenia patients than in the general population. One study indicates that neuroleptic treatment may be an important contributor. Other reports, however, suggest that cognitive impairment in elderly schizophrenia patients is seldom due to Alzheimer-type pathology, indicating that more detailed follow-up studies are needed. Since multiple epidemiological studies show that Alzheimer's disease is less prevalent in patients with medical conditions requiring anti-inflammatory drugs than in the general population, anti-inflammatory medication might be considered as an adjuvant to chronic neuroleptic treatment in elderly schizophrenia patients showing early signs of Alzheimer-type memory deficits.

Journal Article.  0 words. 

Subjects: Child and Adolescent Psychiatry

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.